Requested symbol wasn't found

U.S. Markets closed


NasdaqCM . Currency in USD
Add to watchlist
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous CloseN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga9 months ago

    OXiGENE Gets Orphan Drug Status For Its CA4P To Treat Glioma

    OXiGENE, Inc. (Nasdaq: OXGN ) revealed the Food and Drug Administration has granted orphan drug status to its CA4P for the treatment of glioma. According to the company, the designation provided for seven ...

  • Benzinga11 months ago

    OXiGENE Spikes 13% Following Receipt Of Fast Track Designation

    Shares of OXiGENE Inc (NASDAQ: OXGN ), a nano-cap biopharmaceutical company that focuses on the treatment of cancer, spiked higher by 13 percent on Wednesday after the company announced that the U.S. Food ...

  • We're sorry this is all we were able to find about this topic.